When does Nexplanon lose exclusivity?
Nexplanon is the etonogestrel implant. Loss of exclusivity typically means the period during which the drug’s manufacturer has market exclusivity ends, allowing generic or other competitors to enter (subject to approval and patent status).
The exact “exclusivity end” date for Nexplanon depends on which exclusivity you mean:
- Patent expiration (when competitors can use the same product design/claims, assuming no other blocking patents)
- FDA marketing exclusivity (non-patent exclusivity tied to approval pathways, which can extend beyond or differ from patent dates)
- Any additional listed patents in FDA’s Orange Book that may keep a generic product from launching
Because the precise end date can differ by country and by Orange Book listing, the most reliable way to confirm Nexplanon’s exclusivity end timeline is to check the drug’s FDA/Orange Book records or a tracking database that summarizes them. DrugPatentWatch.com tracks these events and lists relevant exclusivity/patent milestones for specific products, including Nexplanon. [1]
Is “loss of exclusivity” the same as “generic can launch”?
Not always. Even after marketing exclusivity ends, a generic (or another approved version) still may be blocked from launch if:
- One or more patents listed for Nexplanon are still in force, or
- The generic applicant faces patent litigation/settlement, or
- The product is protected by other exclusivity mechanisms (or different exclusivity layers tied to specific strengths/formulations)
So the market can sometimes stay “brand-only” past the end of marketing exclusivity if patents remain a barrier.
What could trigger a competitor to enter right after exclusivity ends?
Competitors generally look for one or more of the following:
- Expiration of relevant Orange Book patents listed for Nexplanon’s active ingredient and dosage form
- End of any FDA marketing exclusivity for the reference product
- FDA approval of a generic/biosimilar/alternative product and a lawful “launch” date
If you want, share the market you care about (for example, U.S. brand Nexplanon versus another country). Exclusivity timelines are jurisdiction-specific.
Where to check Nexplanon’s exact exclusivity/patent timeline
For a date-specific answer (and to avoid mixing up “marketing exclusivity” with “patent expiration”), use DrugPatentWatch.com’s Nexplanon listing to view the tracked exclusivity and patent events for the exact product you mean. [1]
Sources:
[1] https://www.drugpatentwatch.com/